Global and United States Insulin Delivery System Market Insights, Forecast to 2026

Publisher Name :
Date: 24-Nov-2020
No. of pages: 145
Inquire Before Buying

Insulin Delivery System market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Insulin Delivery System market is segmented into

- Insulin Syringes

- Insulin PumpS

- Insulin Pens

Segment by Application, the Insulin Delivery System market is segmented into

- Hospitals

- Home Care

Regional and Country-level Analysis

The Insulin Delivery System market is analysed and market size information is provided by regions (countries).

The key regions covered in the Insulin Delivery System market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Insulin Delivery System Market Share Analysis

Insulin Delivery System market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insulin Delivery System business, the date to enter into the Insulin Delivery System market, Insulin Delivery System product introduction, recent developments, etc.

The major vendors covered:

- BD

- Novo Nordisk

- Sanofi

- Eli Lilly

- Medtronic

- Animas

- Beta Bionics

- Cellnovo

- Copernicus

- Dance Biopharm

- Debiotech

- InsuJet

- Insulet

- MannKind

- Owen Mumford

- Roche

- SHL

- SOOIL

- Tandem Diabetes Care

- Valeritas

- West Pharma

- Ypsomed

Global and United States Insulin Delivery System Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Insulin Delivery System Product Introduction
1.2 Market Segments
1.3 Key Insulin Delivery System Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Insulin Delivery System Market Size Growth Rate by Type
1.4.2 Insulin Syringes
1.4.3 Insulin PumpS
1.4.4 Insulin Pens
1.5 Market by Application
1.5.1 Global Insulin Delivery System Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Insulin Delivery System Market Size, Estimates and Forecasts
2.1.1 Global Insulin Delivery System Revenue 2015-2026
2.1.2 Global Insulin Delivery System Sales 2015-2026
2.2 Global Insulin Delivery System, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Insulin Delivery System Historical Market Size by Region (2015-2020)
2.3.1 Global Insulin Delivery System Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Insulin Delivery System Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Insulin Delivery System Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Insulin Delivery System Sales Forecast by Region (2021-2026)
2.4.2 Global Insulin Delivery System Revenue Forecast by Region (2021-2026)
3 Global Insulin Delivery System Competitor Landscape by Players
3.1 Global Top Insulin Delivery System Sales by Manufacturers
3.1.1 Global Insulin Delivery System Sales by Manufacturers (2015-2020)
3.1.2 Global Insulin Delivery System Sales Market Share by Manufacturers (2015-2020)
3.2 Global Insulin Delivery System Manufacturers by Revenue
3.2.1 Global Insulin Delivery System Revenue by Manufacturers (2015-2020)
3.2.2 Global Insulin Delivery System Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insulin Delivery System Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Insulin Delivery System Revenue in 2019
3.2.5 Global Insulin Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Insulin Delivery System Price by Manufacturers
3.4 Global Insulin Delivery System Manufacturing Base Distribution, Product Types
3.4.1 Insulin Delivery System Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin Delivery System Product Type
3.4.3 Date of International Manufacturers Enter into Insulin Delivery System Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Insulin Delivery System Market Size by Type (2015-2020)
4.1.1 Global Insulin Delivery System Sales by Type (2015-2020)
4.1.2 Global Insulin Delivery System Revenue by Type (2015-2020)
4.1.3 Insulin Delivery System Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Insulin Delivery System Market Size Forecast by Type (2021-2026)
4.2.1 Global Insulin Delivery System Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin Delivery System Revenue Forecast by Type (2021-2026)
4.2.3 Insulin Delivery System Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Insulin Delivery System Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Insulin Delivery System Market Size by Application (2015-2020)
5.1.1 Global Insulin Delivery System Sales by Application (2015-2020)
5.1.2 Global Insulin Delivery System Revenue by Application (2015-2020)
5.1.3 Insulin Delivery System Price by Application (2015-2020)
5.2 Insulin Delivery System Market Size Forecast by Application (2021-2026)
5.2.1 Global Insulin Delivery System Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin Delivery System Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin Delivery System Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Insulin Delivery System Market Size YoY Growth 2015-2026
6.1.1 United States Insulin Delivery System Sales YoY Growth 2015-2026
6.1.2 United States Insulin Delivery System Revenue YoY Growth 2015-2026
6.1.3 United States Insulin Delivery System Market Share in Global Market 2015-2026
6.2 United States Insulin Delivery System Market Size by Players (International and Local Players)
6.2.1 United States Top Insulin Delivery System Players by Sales (2015-2020)
6.2.2 United States Top Insulin Delivery System Players by Revenue (2015-2020)
6.3 United States Insulin Delivery System Historic Market Review by Type (2015-2020)
6.3.1 United States Insulin Delivery System Sales Market Share by Type (2015-2020)
6.3.2 United States Insulin Delivery System Revenue Market Share by Type (2015-2020)
6.3.3 United States Insulin Delivery System Price by Type (2015-2020)
6.4 United States Insulin Delivery System Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Insulin Delivery System Sales Forecast by Type (2021-2026)
6.4.2 United States Insulin Delivery System Revenue Forecast by Type (2021-2026)
6.4.3 United States Insulin Delivery System Price Forecast by Type (2021-2026)
6.5 United States Insulin Delivery System Historic Market Review by Application (2015-2020)
6.5.1 United States Insulin Delivery System Sales Market Share by Application (2015-2020)
6.5.2 United States Insulin Delivery System Revenue Market Share by Application (2015-2020)
6.5.3 United States Insulin Delivery System Price by Application (2015-2020)
6.6 United States Insulin Delivery System Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Insulin Delivery System Sales Forecast by Application (2021-2026)
6.6.2 United States Insulin Delivery System Revenue Forecast by Application (2021-2026)
6.6.3 United States Insulin Delivery System Price Forecast by Application (2021-2026)
7 North America
7.1 North America Insulin Delivery System Market Size YoY Growth 2015-2026
7.2 North America Insulin Delivery System Market Facts & Figures by Country
7.2.1 North America Insulin Delivery System Sales by Country (2015-2020)
7.2.2 North America Insulin Delivery System Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Insulin Delivery System Market Size YoY Growth 2015-2026
8.2 Europe Insulin Delivery System Market Facts & Figures by Country
8.2.1 Europe Insulin Delivery System Sales by Country
8.2.2 Europe Insulin Delivery System Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Insulin Delivery System Market Size YoY Growth 2015-2026
9.2 Asia Pacific Insulin Delivery System Market Facts & Figures by Country
9.2.1 Asia Pacific Insulin Delivery System Sales by Region (2015-2020)
9.2.2 Asia Pacific Insulin Delivery System Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Insulin Delivery System Market Size YoY Growth 2015-2026
10.2 Latin America Insulin Delivery System Market Facts & Figures by Country
10.2.1 Latin America Insulin Delivery System Sales by Country
10.2.2 Latin America Insulin Delivery System Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Insulin Delivery System Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Insulin Delivery System Market Facts & Figures by Country
11.2.1 Middle East and Africa Insulin Delivery System Sales by Country
11.2.2 Middle East and Africa Insulin Delivery System Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 BD
12.1.1 BD Corporation Information
12.1.2 BD Description and Business Overview
12.1.3 BD Sales, Revenue and Gross Margin (2015-2020)
12.1.4 BD Insulin Delivery System Products Offered
12.1.5 BD Recent Development
12.2 Novo Nordisk
12.2.1 Novo Nordisk Corporation Information
12.2.2 Novo Nordisk Description and Business Overview
12.2.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novo Nordisk Insulin Delivery System Products Offered
12.2.5 Novo Nordisk Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Description and Business Overview
12.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Insulin Delivery System Products Offered
12.3.5 Sanofi Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Corporation Information
12.4.2 Eli Lilly Description and Business Overview
12.4.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Lilly Insulin Delivery System Products Offered
12.4.5 Eli Lilly Recent Development
12.5 Medtronic
12.5.1 Medtronic Corporation Information
12.5.2 Medtronic Description and Business Overview
12.5.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Medtronic Insulin Delivery System Products Offered
12.5.5 Medtronic Recent Development
12.6 Animas
12.6.1 Animas Corporation Information
12.6.2 Animas Description and Business Overview
12.6.3 Animas Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Animas Insulin Delivery System Products Offered
12.6.5 Animas Recent Development
12.7 Beta Bionics
12.7.1 Beta Bionics Corporation Information
12.7.2 Beta Bionics Description and Business Overview
12.7.3 Beta Bionics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Beta Bionics Insulin Delivery System Products Offered
12.7.5 Beta Bionics Recent Development
12.8 Cellnovo
12.8.1 Cellnovo Corporation Information
12.8.2 Cellnovo Description and Business Overview
12.8.3 Cellnovo Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Cellnovo Insulin Delivery System Products Offered
12.8.5 Cellnovo Recent Development
12.9 Copernicus
12.9.1 Copernicus Corporation Information
12.9.2 Copernicus Description and Business Overview
12.9.3 Copernicus Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Copernicus Insulin Delivery System Products Offered
12.9.5 Copernicus Recent Development
12.10 Dance Biopharm
12.10.1 Dance Biopharm Corporation Information
12.10.2 Dance Biopharm Description and Business Overview
12.10.3 Dance Biopharm Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Dance Biopharm Insulin Delivery System Products Offered
12.10.5 Dance Biopharm Recent Development
12.11 BD
12.11.1 BD Corporation Information
12.11.2 BD Description and Business Overview
12.11.3 BD Sales, Revenue and Gross Margin (2015-2020)
12.11.4 BD Insulin Delivery System Products Offered
12.11.5 BD Recent Development
12.12 InsuJet
12.12.1 InsuJet Corporation Information
12.12.2 InsuJet Description and Business Overview
12.12.3 InsuJet Sales, Revenue and Gross Margin (2015-2020)
12.12.4 InsuJet Products Offered
12.12.5 InsuJet Recent Development
12.13 Insulet
12.13.1 Insulet Corporation Information
12.13.2 Insulet Description and Business Overview
12.13.3 Insulet Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Insulet Products Offered
12.13.5 Insulet Recent Development
12.14 MannKind
12.14.1 MannKind Corporation Information
12.14.2 MannKind Description and Business Overview
12.14.3 MannKind Sales, Revenue and Gross Margin (2015-2020)
12.14.4 MannKind Products Offered
12.14.5 MannKind Recent Development
12.15 Owen Mumford
12.15.1 Owen Mumford Corporation Information
12.15.2 Owen Mumford Description and Business Overview
12.15.3 Owen Mumford Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Owen Mumford Products Offered
12.15.5 Owen Mumford Recent Development
12.16 Roche
12.16.1 Roche Corporation Information
12.16.2 Roche Description and Business Overview
12.16.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Roche Products Offered
12.16.5 Roche Recent Development
12.17 SHL
12.17.1 SHL Corporation Information
12.17.2 SHL Description and Business Overview
12.17.3 SHL Sales, Revenue and Gross Margin (2015-2020)
12.17.4 SHL Products Offered
12.17.5 SHL Recent Development
12.18 SOOIL
12.18.1 SOOIL Corporation Information
12.18.2 SOOIL Description and Business Overview
12.18.3 SOOIL Sales, Revenue and Gross Margin (2015-2020)
12.18.4 SOOIL Products Offered
12.18.5 SOOIL Recent Development
12.19 Tandem Diabetes Care
12.19.1 Tandem Diabetes Care Corporation Information
12.19.2 Tandem Diabetes Care Description and Business Overview
12.19.3 Tandem Diabetes Care Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Tandem Diabetes Care Products Offered
12.19.5 Tandem Diabetes Care Recent Development
12.20 Valeritas
12.20.1 Valeritas Corporation Information
12.20.2 Valeritas Description and Business Overview
12.20.3 Valeritas Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Valeritas Products Offered
12.20.5 Valeritas Recent Development
12.21 West Pharma
12.21.1 West Pharma Corporation Information
12.21.2 West Pharma Description and Business Overview
12.21.3 West Pharma Sales, Revenue and Gross Margin (2015-2020)
12.21.4 West Pharma Products Offered
12.21.5 West Pharma Recent Development
12.22 Ypsomed
12.22.1 Ypsomed Corporation Information
12.22.2 Ypsomed Description and Business Overview
12.22.3 Ypsomed Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Ypsomed Products Offered
12.22.5 Ypsomed Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Insulin Delivery System Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin Delivery System Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Insulin Delivery System Market Segments
Table 2. Ranking of Global Top Insulin Delivery System Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Delivery System Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Insulin Syringes
Table 5. Major Manufacturers of Insulin PumpS
Table 6. Major Manufacturers of Insulin Pens
Table 7. Global Insulin Delivery System Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Insulin Delivery System Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Insulin Delivery System Sales by Regions 2015-2020 (K Units)
Table 10. Global Insulin Delivery System Sales Market Share by Regions (2015-2020)
Table 11. Global Insulin Delivery System Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Insulin Delivery System Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Insulin Delivery System Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Insulin Delivery System Sales Share by Manufacturers (2015-2020)
Table 15. Global Insulin Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Insulin Delivery System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Delivery System as of 2019)
Table 17. Insulin Delivery System Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Insulin Delivery System Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Insulin Delivery System Price (2015-2020) (USD/Unit)
Table 20. Insulin Delivery System Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Insulin Delivery System Product Type
Table 22. Date of International Manufacturers Enter into Insulin Delivery System Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Insulin Delivery System Sales by Type (2015-2020) (K Units)
Table 25. Global Insulin Delivery System Sales Share by Type (2015-2020)
Table 26. Global Insulin Delivery System Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Insulin Delivery System Revenue Share by Type (2015-2020)
Table 28. Insulin Delivery System Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Insulin Delivery System Sales Share by Type (2021-2026)
Table 30. Global Insulin Delivery System Sales by Application (2015-2020) (K Units)
Table 31. Global Insulin Delivery System Sales Share by Application (2015-2020)
Table 32. Global Insulin Delivery System Sales Share by Application (2021-2026)
Table 33. Global Insulin Delivery System Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Insulin Delivery System Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Insulin Delivery System Revenue Market Share Forecast by Application (2021-2026)
Table 36. United States Insulin Delivery System Sales (K Units) of Key Companies (2015-2020)
Table 37. United States Insulin Delivery System Sales Share by Company (2015-2020)
Table 38. United States Insulin Delivery System Revenue (US$ Million) by Company (2015-2020)
Table 39. United States Insulin Delivery System Sales (K Units) by Type (2015-2020)
Table 40. United States Insulin Delivery System Sales Share by Type (2015-2020)
Table 41. United States Insulin Delivery System Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. United States Insulin Delivery System Price (K Units) by Type (2015-2020)
Table 43. United States Insulin Delivery System Sales (K Units) by Type (2021-2026)
Table 44. United States Insulin Delivery System Sales Share by Type (2021-2026)
Table 45. United States Insulin Delivery System Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. United States Insulin Delivery System Revenue Share by Type (2021-2026)
Table 47. United States Insulin Delivery System Price (K Units) by Type (2021-2026)
Table 48. United States Insulin Delivery System Sales (K Units) by Application (2015-2020)
Table 49. United States Insulin Delivery System Sales Share by Application (2015-2020)
Table 50. United States Insulin Delivery System Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. United States Insulin Delivery System Sales (K Units) by Application (2021-2026)
Table 52. United States Insulin Delivery System Sales Share by Application (2021-2026)
Table 53. United States Insulin Delivery System Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. United States Insulin Delivery System Revenue Share by Application (2021-2026)
Table 55. North America Insulin Delivery System Sales by Country (2015-2020) (K Units)
Table 56. North America Insulin Delivery System Sales Market Share by Country (2015-2020)
Table 57. North America Insulin Delivery System Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Insulin Delivery System Revenue Market Share by Country (2015-2020)
Table 59. Europe Insulin Delivery System Sales by Country (2015-2020) (K Units)
Table 60. Europe Insulin Delivery System Sales Market Share by Country (2015-2020)
Table 61. Europe Insulin Delivery System Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Insulin Delivery System Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Insulin Delivery System Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Insulin Delivery System Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Insulin Delivery System Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Insulin Delivery System Revenue Market Share by Region (2015-2020)
Table 67. Latin America Insulin Delivery System Sales by Country (2015-2020) (K Units)
Table 68. Latin America Insulin Delivery System Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Insulin Delivery System Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Insulin Delivery System Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Insulin Delivery System Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Insulin Delivery System Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Insulin Delivery System Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Insulin Delivery System Revenue Market Share by Country (2015-2020)
Table 75. BD Corporation Information
Table 76. BD Description and Business Overview
Table 77. BD Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. BD Insulin Delivery System Product
Table 79. BD Recent Development
Table 80. Novo Nordisk Corporation Information
Table 81. Novo Nordisk Description and Business Overview
Table 82. Novo Nordisk Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Novo Nordisk Product
Table 84. Novo Nordisk Recent Development
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Sanofi Product
Table 89. Sanofi Recent Development
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Eli Lilly Product
Table 94. Eli Lilly Recent Development
Table 95. Medtronic Corporation Information
Table 96. Medtronic Description and Business Overview
Table 97. Medtronic Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Medtronic Product
Table 99. Medtronic Recent Development
Table 100. Animas Corporation Information
Table 101. Animas Description and Business Overview
Table 102. Animas Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Animas Product
Table 104. Animas Recent Development
Table 105. Beta Bionics Corporation Information
Table 106. Beta Bionics Description and Business Overview
Table 107. Beta Bionics Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Beta Bionics Product
Table 109. Beta Bionics Recent Development
Table 110. Cellnovo Corporation Information
Table 111. Cellnovo Description and Business Overview
Table 112. Cellnovo Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Cellnovo Product
Table 114. Cellnovo Recent Development
Table 115. Copernicus Corporation Information
Table 116. Copernicus Description and Business Overview
Table 117. Copernicus Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Copernicus Product
Table 119. Copernicus Recent Development
Table 120. Dance Biopharm Corporation Information
Table 121. Dance Biopharm Description and Business Overview
Table 122. Dance Biopharm Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Dance Biopharm Product
Table 124. Dance Biopharm Recent Development
Table 125. Debiotech Corporation Information
Table 126. Debiotech Description and Business Overview
Table 127. Debiotech Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Debiotech Product
Table 129. Debiotech Recent Development
Table 130. InsuJet Corporation Information
Table 131. InsuJet Description and Business Overview
Table 132. InsuJet Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. InsuJet Product
Table 134. InsuJet Recent Development
Table 135. Insulet Corporation Information
Table 136. Insulet Description and Business Overview
Table 137. Insulet Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Insulet Product
Table 139. Insulet Recent Development
Table 140. MannKind Corporation Information
Table 141. MannKind Description and Business Overview
Table 142. MannKind Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. MannKind Product
Table 144. MannKind Recent Development
Table 145. Owen Mumford Corporation Information
Table 146. Owen Mumford Description and Business Overview
Table 147. Owen Mumford Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Owen Mumford Product
Table 149. Owen Mumford Recent Development
Table 150. Roche Corporation Information
Table 151. Roche Description and Business Overview
Table 152. Roche Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Roche Product
Table 154. Roche Recent Development
Table 155. SHL Corporation Information
Table 156. SHL Description and Business Overview
Table 157. SHL Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. SHL Product
Table 159. SHL Recent Development
Table 160. SOOIL Corporation Information
Table 161. SOOIL Description and Business Overview
Table 162. SOOIL Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. SOOIL Product
Table 164. SOOIL Recent Development
Table 165. Tandem Diabetes Care Corporation Information
Table 166. Tandem Diabetes Care Description and Business Overview
Table 167. Tandem Diabetes Care Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Tandem Diabetes Care Product
Table 169. Tandem Diabetes Care Recent Development
Table 170. Valeritas Corporation Information
Table 171. Valeritas Description and Business Overview
Table 172. Valeritas Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. Valeritas Product
Table 174. Valeritas Recent Development
Table 175. West Pharma Corporation Information
Table 176. West Pharma Description and Business Overview
Table 177. West Pharma Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 178. West Pharma Product
Table 179. West Pharma Recent Development
Table 180. Ypsomed Corporation Information
Table 181. Ypsomed Description and Business Overview
Table 182. Ypsomed Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 183. Ypsomed Product
Table 184. Ypsomed Recent Development
Table 185. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 186. Key Challenges
Table 187. Market Risks
Table 188. Main Points Interviewed from Key Insulin Delivery System Players
Table 189. Insulin Delivery System Customers List
Table 190. Insulin Delivery System Distributors List
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Delivery System Product Picture
Figure 2. Global Insulin Delivery System Sales Market Share by Type in 2020 & 2026
Figure 3. Insulin Syringes Product Picture
Figure 4. Insulin PumpS Product Picture
Figure 5. Insulin Pens Product Picture
Figure 6. Global Insulin Delivery System Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Home Care
Figure 9. Insulin Delivery System Report Years Considered
Figure 10. Global Insulin Delivery System Market Size 2015-2026 (US$ Million)
Figure 11. Global Insulin Delivery System Sales 2015-2026 (K Units)
Figure 12. Global Insulin Delivery System Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Insulin Delivery System Sales Market Share by Region (2015-2020)
Figure 14. Global Insulin Delivery System Sales Market Share by Region in 2019
Figure 15. Global Insulin Delivery System Revenue Market Share by Region (2015-2020)
Figure 16. Global Insulin Delivery System Revenue Market Share by Region in 2019
Figure 17. Global Insulin Delivery System Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Insulin Delivery System Revenue in 2019
Figure 19. Insulin Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Insulin Delivery System Sales Market Share by Type (2015-2020)
Figure 21. Global Insulin Delivery System Sales Market Share by Type in 2019
Figure 22. Global Insulin Delivery System Revenue Market Share by Type (2015-2020)
Figure 23. Global Insulin Delivery System Revenue Market Share by Type in 2019
Figure 24. Global Insulin Delivery System Market Share by Price Range (2015-2020)
Figure 25. Global Insulin Delivery System Sales Market Share by Application (2015-2020)
Figure 26. Global Insulin Delivery System Sales Market Share by Application in 2019
Figure 27. Global Insulin Delivery System Revenue Market Share by Application (2015-2020)
Figure 28. Global Insulin Delivery System Revenue Market Share by Application in 2019
Figure 29. United States Insulin Delivery System Sales Growth Rate 2015-2026 (K Units)
Figure 30. United States Insulin Delivery System Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. United States Insulin Delivery System Market Share in Global Market 2015-2026
Figure 32. United States 5 and 10 Largest Insulin Delivery System Players Market Share by Revenue in Insulin Delivery System in 2019
Figure 33. United States Insulin Delivery System Revenue Share by Type (2015-2020)
Figure 34. United States Insulin Delivery System Revenue Growth Rate by Type in 2015 & 2019
Figure 35. United States Insulin Delivery System Revenue Share by Application (2015-2020)
Figure 36. United States Insulin Delivery System Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Insulin Delivery System Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Insulin Delivery System Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Insulin Delivery System Sales Market Share by Country in 2019
Figure 40. North America Insulin Delivery System Revenue Market Share by Country in 2019
Figure 41. U.S. Insulin Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Insulin Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Insulin Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Insulin Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Insulin Delivery System Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Insulin Delivery System Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Insulin Delivery System Sales Market Share by Country in 2019
Figure 48. Europe Insulin Delivery System Revenue Market Share by Country in 2019
Figure 49. Germany Insulin Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Insul
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs